Skip to content
GLP-1 Scorecard
Menu
Site position #409

Open Water Rx

Published by GLP-1 ScorecardUpdated

Open Water Rx is a telehealth platform positioned around GLP-1 weight loss and longevity, per its own site.

Visit Open Water RxWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$249/mo (compounded)
Tirzepatide
$339/mo (compounded)
Coverage
Coverage not published
Brand-name
Yes

Weigh Open Water Rx against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value48/100
Dose & formulation88/100
Clinical oversight54/100
Labs & monitoring60/100
Fulfillment42/100
Contract terms55/100

Strengths

  • Combines weight-loss and longevity verticals in one brand
  • Established brand domain

What to consider

  • Limited public data — most details are gated behind signup or rendered only in JavaScript
  • Pricing not disclosed
  • GLP-1 options (semaglutide vs. tirzepatide, compounded vs. brand, injection vs. oral) not stated
  • States-served list not disclosed
  • Pharmacy partner not named

Bottom line — Grade C

Best for: Shoppers who want transparency listing only — verify against vetted providers first.

Site position #409 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest Open Water Rx — the realistic shortlist.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Open Water Rx's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Open Water Rx's site. Not medical advice; see our disclosure.

← Back to the scorecard